Edition:
United Kingdom

Acadia Pharma Reports Second Quarter Loss Per Share Of $0.38


Wednesday, 31 Jul 2019 

July 31 (Reuters) - ACADIA Pharmaceuticals Inc ::ACADIA PHARMACEUTICALS REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.38.Q2 SALES $83.2 MILLION VERSUS REFINITIV IBES ESTIMATE OF $72.6 MILLION.SEES FY 2019 SALES $320 MILLION TO $330 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $-0.45 -- REFINITIV IBES DATA.ACADIA PHARMACEUTICALS - AT JUNE 30, 2019, ACADIA'S CASH, CASH EQUIVALENTS, AND INVESTMENT SECURITIES TOTALED $381.9 MILLION.2019 GAAP SG&A GUIDANCE IS INCREASED TO $300 MILLION TO $315 MILLION.